002880 衛光生物
按盤價 
25.970 +0.130 (+0.503%)
25.970 +0.130 (+0.503%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.961 | 11.999 | 11.343 | 6.511 | 12.183 |
| 總資產報酬率 ROA (%) | 4.718 | 8.212 | 8.020 | 5.132 | 10.701 |
| 投入資產回報率 ROIC (%) | 5.296 | 9.257 | 8.809 | 5.564 | 11.699 | 邊際利潤分析 |
| 銷售毛利率 (%) | 42.471 | 41.878 | 41.320 | 36.068 | 40.875 |
| 營業利潤率 (%) | 23.364 | 24.653 | 23.587 | 20.686 | 26.640 |
| 息稅前利潤/營業總收入 (%) | 25.123 | 26.353 | 24.601 | 20.338 | 25.933 |
| 淨利潤/營業總收入 (%) | 19.954 | 21.107 | 20.748 | 18.147 | 22.590 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.138 | 102.135 | 90.607 | 80.089 | 96.760 |
| 價值變動淨收益/利潤總額(%) | 1.712 | -2.917 | 3.028 | 13.605 | 0.305 |
| 營業外收支淨額/利潤總額(%) | -0.364 | 0.038 | -0.755 | -0.619 | -0.235 | 償債能力分析 |
| 流動比率 (X) | 2.920 | 3.613 | 4.149 | 4.932 | 5.979 |
| 速動比率 (X) | 0.822 | 1.737 | 1.619 | 2.296 | 3.456 |
| 資產負債率 (%) | 30.565 | 31.940 | 28.891 | 27.493 | 10.743 |
| 帶息債務/全部投入資本 (%) | 21.050 | 21.539 | 18.183 | 21.319 | 0.264 |
| 股東權益/帶息債務 (%) | 362.425 | 352.116 | 432.487 | 359.395 | 36,801.506 |
| 股東權益/負債合計 (%) | 224.014 | 209.970 | 242.351 | 259.953 | 821.783 |
| 利息保障倍數 (X) | 13.626 | 15.591 | 20.649 | -92.217 | -40.235 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 52.629 | 28.165 | 27.167 | 62.315 | 46.745 |
| 存貨周轉天數 (天) | 522.231 | 377.450 | 374.036 | 432.981 | 270.273 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
